increased solubility = different PK profile? [Dissolution / BCS / IVIVC]

posted by Dr_Dan  – Germany, 2017-06-08 19:36 (2506 d 10:49 ago) – Posting: # 17466
Views: 14,032

O.k., I see I need to add some more information. The idea behind this question is to develop an oral formulation with a less drug load than the reference product but with the same bioavailability in order to decrease non-systemic adverse events.

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,666 registered users;
66 visitors (0 registered, 66 guests [including 7 identified bots]).
Forum time: 06:26 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5